Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / Senate Bills / S. 1095

S. 1095

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2025-03-246.3K⠃⠗⠋
Reported in Senate2025-04-106.4K⠃⠗⠋